AFT Pharmaceuticals
AFT.NZ
#8716
Rank
ยฃ0.19 B
Marketcap
ยฃ1.84
Share price
-0.23%
Change (1 day)
60.49%
Change (1 year)

Revenue for AFT Pharmaceuticals (AFT.NZ)

Revenue in 2026: ยฃ0.10 Billion

According to AFT Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is ยฃ0.10 Billion. In 2026 the company made a revenue of ยฃ0.10 Billion an increase over the revenue in the year 2025 that were of ยฃ86.97 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for AFT Pharmaceuticals from 2016 to 2026

Annual revenue

Year Revenue Change
2026ยฃ0.10 B24.08%
2025ยฃ86.97 M0.31%
2024ยฃ86.7 M19.03%
2023ยฃ72.84 M8.4%
2022ยฃ67.19 M13.98%
2021ยฃ58.95 M25.69%
2020ยฃ46.9 M8.18%
2019ยฃ43.36 M0.5%
2018ยฃ43.14 M19.09%
2017ยฃ36.22 M9.56%
2016ยฃ33.06 M